Sarepta Therapeutics (SRPT) Asset Utilization Ratio (2013 - 2026)
Sarepta Therapeutics' quarterly Asset Utilization Ratio came in at 0.57 in Q1 2026, up 30.05% year-on-year from 0.44 in Q1 2025, and up 22.45% quarter-over-quarter from 0.46 in Q4 2025.
Sarepta Therapeutics has reported Asset Utilization Ratio for 12 years, with the latest figure at 0.57 in Q1 2026.
- For the quarter ending Q1 2026, Asset Utilization Ratio rose 30.05% year-over-year to 0.57; the trailing twelve-month figure through Mar 2026 stood at 0.57 (up 30.05% YoY), and the FY2025 full-year result was 0.6, up 14.23% from the prior year.
- Asset Utilization Ratio for Q1 2026 stood at 0.57, up from 0.46 in the prior quarter.
- The five-year high for Asset Utilization Ratio was 0.57 in Q1 2026, with the low at 0.15 in Q1 2022.
- Average Asset Utilization Ratio over 5 years is 0.36, with a median of 0.38 recorded in 2024.
- Year-over-year, Asset Utilization Ratio jumped 124.04% in 2024 and fell 7.8% in 2025.
- Tracing SRPT's Asset Utilization Ratio over 5 years: stood at 0.19 in 2022, then soared by 73.07% to 0.34 in 2023, then surged by 49.66% to 0.5 in 2024, then slipped by 7.8% to 0.46 in 2025, then grew by 22.45% to 0.57 in 2026.
- The last three Asset Utilization Ratio figures came in at 0.57 (Q1 2026), 0.46 (Q4 2025), and 0.5 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 0.60 |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 0.47 |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 0.29 |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 0.37 |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 0.85 |
| 10 | Sarepta Therapeutics | 1.86 Bn | 1.17 Bn | 291.52 Mn | 0.57 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.57 |
| Dec 31, 2025 | 0.46 |
| Sep 30, 2025 | 0.50 |
| Jun 30, 2025 | 0.52 |
| Mar 31, 2025 | 0.44 |
| Dec 31, 2024 | 0.50 |
| Sep 30, 2024 | 0.49 |
| Jun 30, 2024 | 0.47 |
| Mar 31, 2024 | 0.38 |
| Dec 31, 2023 | 0.34 |
| Sep 30, 2023 | 0.25 |
| Jun 30, 2023 | 0.21 |
| Mar 31, 2023 | 0.27 |
| Dec 31, 2022 | 0.19 |
| Sep 30, 2022 | 0.18 |
| Jun 30, 2022 | 0.18 |
| Mar 31, 2022 | 0.15 |
| Dec 31, 2021 | 0.20 |
| Sep 30, 2021 | 0.18 |
| Jun 30, 2021 | 0.12 |
| Mar 31, 2021 | 0.08 |
| Dec 31, 2020 | 0.03 |
| Sep 30, 2020 | 0.06 |
| Jun 30, 2020 | 0.08 |
| Mar 31, 2020 | 0.13 |
| Dec 31, 2019 | 0.22 |
| Sep 30, 2019 | 0.21 |
| Jun 30, 2019 | 0.19 |
| Mar 31, 2019 | 0.18 |
| Dec 31, 2018 | 0.21 |
| Sep 30, 2018 | 0.23 |
| Jun 30, 2018 | 0.19 |
| Mar 31, 2018 | 0.16 |
| Dec 31, 2017 | 0.15 |
| Sep 30, 2017 | 0.16 |
| Jun 30, 2017 | 0.11 |
| Mar 31, 2017 | 0.04 |
| Dec 31, 2014 | 0.03 |
| Sep 30, 2014 | 0.04 |
| Jun 30, 2014 | 0.05 |
| Mar 31, 2014 | 0.06 |
| Dec 31, 2013 | 0.05 |
| Sep 30, 2013 | 0.08 |
| Jun 30, 2013 | 0.12 |
| Mar 31, 2013 | 0.15 |